|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PVAC™ is an immunomodulator for the treatment of psoriasis. In February 2001, we reported interim results from a Phase II clinical trial of PVAC treatment in the United States. A Phase II clinical trial is also underway in Brazil under a U.S. IND. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A business overview as well as information on Corixa's partners, management team, employment opportunities, and company contacts.
Corixa's near-term products and adjuvant for research applications.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.
Company reports, stockholder letter, events calendar, stock quote, analyst list, and materials request.
Current and archived company press releases.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.
Glossary 